PubMed Health⌕ Search

Biomedical subjects

R R Cook

Publications and source records attributed to R R Cook.

At least 37 records · Page 2Linked to original sources

An update of mortality among chemical workers potentially exposed to the herbicide 2,4-dichlorophenoxyacetic acid and its derivatives.

Four years of additional mortality follow-up through 1986 are reported for a previously studied cohort of 878 chemical workers who were potentially exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) and its derivatives between 1945 and 1983. Observed mortality was compared with expected levels based on death rates of the US population and of 36,804 "unexposed" workers from the same manufacturing location. Non-Hodgkin's lymphoma (NHL) was a particular focus of the study because of a suggested association with 2,4-D exposure in some case-control studies. For the total observation period, the standardized mortality ratios for all causes and for malignant neoplasms were 92 and 91, respectively. Analyses using the internal comparison group yielded virtually identical results. The initial study had found two deaths from NHL, both of which occurred under circumstances (ie, short latency and modest exposure) which made it less plausible that they were related to 2,4-D exposure. No new deaths from NHL were observed in the extended follow-up period and mortality for this cause showed a nonstatistically significant excess (standardized mortality ratio, 196; 95% confidence interval 24 to 708) for the total observation period. Analyses by production area, and by two different measures of exposure, combined with two different approaches to account for latency, did not show patterns suggestive of a causal relationship between exposure to 2,4-D or its derivatives and any particular cause of death.

2,4-Dichlorophenoxyacetic Acid↗

Preliminary evaluation of an employer-sponsored mammography screening program.

Recognizing the importance of early detection of breast cancer, the Dow Chemical Company initiated a breast cancer awareness program in 1988. Evaluation of operational aspects of mammography screening component revealed that about half (53%) of 1186 eligible women in the evaluation cohort took part, although participation was three times higher for active than for retired employees. Eleven per cent of participants were considered to have "positive" screens, ie, had roentgenogram films with suspicious areas, and at least 82% of these women had follow-up medical services within 1 year of screening, as determined by a review of group insurance claims records. Two women with positive mammograms were subsequently diagnosed and treated for breast cancer within 2 months of screening. None of the women with negative mammograms developed breast cancer in the subsequent year. The suitability of group insurance data resources for responding to health care delivery questions is discussed.

Adult↗

Mortality among workers engaged in the development or manufacture of styrene-based products--an update.

Mortality was updated another 11 years through 1986 for a previously studied cohort of 2904 male chemical workers who were potentially exposed to styrene and related materials for a year or more between 1937 and 1971. Substantial deficits in mortality from all causes and total cancer were observed in the cohort when it was compared with white males in the United States, and also other chemical workers who were unexposed to styrene-based products. Mortality from leukemia was slightly less than expected during the updated period, in contrast to an excess of lymphatic leukemia observed in the original period. Yet small elevations in risk of other types of lymphatic cancer, particularly multiple myeloma, persisted. The risk of these cancers did not increase with estimated intensity or duration of styrene exposure. The findings are discussed in context with those of studies of similarly exposed workers in related industries.

Cause of Death↗

Code of ethics for epidemiologists.

The importance of a written code of ethics for epidemiologists is growing. This paper explores the reasons for developing such a code and the issues that should be addressed during its implementation. It concludes with recommendations on format and content. The latter includes sections on obligations epidemiologists have to subjects, society, funders and employers and colleagues.

Bias↗

A comparison of cause-specific mortality among participants and nonparticipants in a work-site medical surveillance program.

Nonparticipants in general population health surveys have been found to be less healthy than participants, but data on nonparticipants in work-site health surveys have been more scarce. We compared cause-specific mortality among 11,156 male employees of The Dow Chemical Company who participated in at least one work-site health examination between 1967 and 1978 with 6915 employees who did not participate. The nonparticipants experienced higher mortality rates for nearly every cause of death examined but particularly from smoking and alcohol-abuse related diseases. This was especially true during the first 5 years of follow-up, suggesting that some employees do not participate because they are already ill. These findings have important implications for the use of examination data for both primary and secondary disease prevention purposes, and these are discussed.

Adult↗

Overview of good epidemiologic practices.

The results of epidemiologic research are increasingly being used by those who establish health policy in the private and public sector. To increase the contribution such information might make to the decision-making process, a number of organizations have made recommendations for improvements in epidemiologic practices. ERIC, the Epidemiology Resource Information Center, a pilot project of the Chemical Manufacturers Association, has developed "Guidelines for Good Epidemiology Practices." This document provides recommendations regarding organization and personnel; facilities, resource commitment, and contractors; protocol; review and approval procedures; study conduct; communication of study results; archiving of study materials and data; and quality assurance. Although intended for use by those in the private sector who conduct environmental and industrial epidemiology, it should have utility for the entire profession.

Chemical Industry↗